Scribd Logo
Upload

Welcome to Scribd!

  • Neuroprotection - Drugs, Markets and Companies Part 2

    Uploaded by

    Peter Barfoot
    39 views1 page
    To purchase please return to: http://www.bioportfolio.net/report/3794-neuroprotection-drugs-markets-and-companies.html Pathomechanisms of diseases are described with steps at which neuroprotective therapies are directed. Diseases covered include cerebrovascular disorders, traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy and ischemic optic neuropathy as well as retinal degeneration. Although anesthetics such as propofol are neuroprotective as well, neuroprotection during surgery and anesthesia is discussed with the aim of preventing and treating complications that result in CNS damage.

    Copyright

    © © All Rights Reserved

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    To purchase please return to: http://www.bioportfolio.net/report/3794-neuroprotection-drugs-markets-and-companies.html Pathomechanisms of diseases are described with steps at which neuroprotective therapies are directed. Diseases covered include cerebrovascular disorders, traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy and ischemic optic neuropathy as well as retinal degeneration. Although anesthetics such as propofol are neuroprotective as well, neuroprotection during surgery and anesthesia is discussed with the aim of preventing and treating complications that result in CNS damage.

    Copyright:

    © All Rights Reserved
    Flag for inappropriate content
    39 views1 page

    Neuroprotection - Drugs, Markets and Companies Part 2

    Uploaded by

    Peter Barfoot
    To purchase please return to: http://www.bioportfolio.net/report/3794-neuroprotection-drugs-markets-and-companies.html Pathomechanisms of diseases are described with steps at which neuroprotective therapies are directed. Diseases covered include cerebrovascular disorders, traumatic brain injury, spinal cord injury, Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy and ischemic optic neuropathy as well as retinal degeneration. Although anesthetics such as propofol are neuroprotective as well, neuroprotection during surgery and anesthesia is discussed with the aim of preventing and treating complications that result in CNS damage.

    Copyright:

    © All Rights Reserved
    Flag for inappropriate content
    of 1

    TABLE

    OF

    CONTENTS

    16. Companies Developing Neuroprotective Therapies ............................... 5


    Introduction ........................................................................................................................ 5
    Profiles of companies........................................................................................................... 5
    Collaborations.................................................................................................................. 152

    Tables
    Table 16-1: Neuroprotectives in development by AstraZeneca ......................................................... 22
    Table 16-2: Collaborations of companies in the area of neuroprotection.......................................... 152

    -3-

    You might also like